#United States #New York #Class Action #Pomerantz LLP #SelectQuote

Investor Alert: Class Action Lawsuit Against SelectQuote, Inc.

On October 8, 2025, Pomerantz LLP announced that a class action lawsuit has been filed against SelectQuote, Inc. (NYSE: SLQT). This comes as a critical announcement for investors who may have sustained losses linked to their investments in SelectQuote. The firm is advising these investors to reach out for further information regarding their legal rights and options.

Details of the Class Action

The lawsuit concerns allegations of securities fraud and other illicit business practices purportedly engaged in by SelectQuote and its leadership. For investors who acquired SelectQuote stock during the specified Class Period, there is a pressing deadline. They must act by October 10, 2025, to potentially serve as Lead Plaintiff in this action.

Danielle Peyton from Pomerantz LLP can be reached at 646-581-9980 or via email for interested parties seeking to join the litigation. Investors are encouraged to provide their mailing addresses, telephone numbers, and details of shares purchased when inquiring.

The Allegations

The allegations stem from a False Claims Act complaint filed by the U.S. Department of Justice (DOJ) against SelectQuote earlier in 2025. According to the DOJ, between 2016 and 2021, SelectQuote allegedly received tens of millions of dollars in illegal kickbacks from health insurance companies in return for directing Medicare beneficiaries to certain insurance plans. It is claimed that these practices included a conspiracy with major insurers to discriminate against beneficiaries perceived as less profitable, including those with disabilities.

The DOJ's claims suggest that SelectQuote made misleading statements about providing unbiased coverage comparisons when, in reality, they were directing beneficiaries towards plans that financially benefited them the most. This deceptive practice has raised significant concerns regarding the company's integrity and operational ethics.

Market Response

The fallout from these allegations was immediate. Following the DOJ’s announcement on May 1, 2025, SelectQuote suffered a significant plunge in its stock price; it fell by $0.61 or 19.24%, closing at $2.56 per share. This might resonate with investors who have seen their investments dwindle due to the scandal.

Pomerantz LLP’s Role

Pomerantz LLP is a renowned law firm with a legacy in corporate securities class litigation. Established by Abraham L. Pomerantz, a pioneer in this field, the firm has a history stretching over 85 years in advocating for victims of securities fraud and corruption. Pomerantz LLP is acclaimed for achieving significant settlements on behalf of their clients in similar litigation contexts, persisting in their battle against corporate malfeasance.

If you are an investor who has been affected by the decline in SelectQuote's stock price or who has suffered losses from your investments, it is crucial to act promptly. The firm remains dedicated to protecting the rights of investors and holding corporations accountable for their actions.

For additional information and to obtain a copy of the Complaint, please visit Pomerantz Law Firm's website. Remember, prior results do not guarantee similar outcomes in future cases.

Conclusion

The proceedings surrounding SelectQuote, Inc. highlight the intricacies of corporate governance and the potential impact of fraudulent practices on shareholders. Investors must stay informed and proactive in protecting their investments in light of ongoing legal developments. For those impacted, reaching out to Pomerantz LLP could provide crucial support during this challenging time.